Castle Biosciences (CSTL) Market Capitalization (2019 - 2026)

Castle Biosciences has disclosed Market Capitalization across 8 years of filings, most recently posting $727.6 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 22.95% year-over-year to $727.6 million; the TTM figure through Jun 2026 stood at $727.6 million (up 22.95% YoY), while the FY2025 annual figure was $1.2 billion, up 52.13% from the prior year.
• Market Capitalization came in at $727.6 million for Q2 2026 at Castle Biosciences, down from $743.8 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.2 billion in Q4 2025 to a low of $367.5 million in Q2 2023.
• Average Market Capitalization over 5 years is $682.4 million, with a median of $618.0 million recorded in 2022.
• Year-over-year, Market Capitalization tumbled 68.72% in 2022 and soared 75.67% in 2024.
• Over 5 years, Market Capitalization stood at $625.1 million in 2022, then slipped by 5.37% to $591.5 million in 2023, then increased by 28.33% to $759.1 million in 2024, then surged by 52.13% to $1.2 billion in 2025, then plunged by 36.99% to $727.6 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $727.6 million in Q2 2026, $743.8 million in Q1 2026, and $1.2 billion in Q4 2025.